Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SEOM clinical guideline in nasopharynx cancer (2017).
Pastor M, Lopez Pousa A, Del Barco E, Perez Segura P, Astorga BG, Castelo B, Bonfill T, Martinez Trufero J, Grau JJ, Mesia R. Pastor M, et al. Among authors: mesia r. Clin Transl Oncol. 2018 Jan;20(1):84-88. doi: 10.1007/s12094-017-1777-0. Epub 2017 Nov 2. Clin Transl Oncol. 2018. PMID: 29098554 Free PMC article.
Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study.
Del Barco Morillo E, Mesía R, Adansa Klain JC, Vázquez Fernández S, Martínez-Galán J, Pastor Borgoñon M, González-Rivas C, Caballero Daroqui J, Berrocal A, Martínez-Trufero J, Vera R, Cruz-Hernández JJ; Spanish Head And Neck Cancer Cooperative Group (TTCC). Del Barco Morillo E, et al. Among authors: mesia r. Oral Oncol. 2016 Nov;62:54-59. doi: 10.1016/j.oraloncology.2016.09.009. Epub 2016 Oct 8. Oral Oncol. 2016. PMID: 27865372 Clinical Trial.
Epidermal growth factor receptor (EGFR) pathway polymorphisms as predictive markers of cetuximab toxicity in locally advanced head and neck squamous cell carcinoma (HNSCC) in a Spanish population.
Fernández-Mateos J, Seijas-Tamayo R, Mesía R, Taberna M, Pastor Borgoñón M, Pérez-Ruiz E, Adansa Klain JC, Vázquez Fernández S, Del Barco Morillo E, Lozano A, González Sarmiento R, Cruz-Hernández JJ; Spanish Head and Neck Cancer Cooperative Group (TTCC). Fernández-Mateos J, et al. Among authors: mesia r. Oral Oncol. 2016 Dec;63:38-43. doi: 10.1016/j.oraloncology.2016.10.006. Epub 2016 Nov 12. Oral Oncol. 2016. PMID: 27938998 Free article.
SEOM clinical guidelines for the treatment of head and neck cancer (2020).
Mesia R, Iglesias L, Lambea J, Martínez-Trufero J, Soria A, Taberna M, Trigo J, Chaves M, García-Castaño A, Cruz J. Mesia R, et al. Clin Transl Oncol. 2021 May;23(5):913-921. doi: 10.1007/s12094-020-02533-1. Epub 2021 Feb 26. Clin Transl Oncol. 2021. PMID: 33635468 Free PMC article.
Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 2).
Rueda A, Giralt J, Mañós M, Lozano A, Sistiaga A, García-Miragall E, Cacicedo J, Esteban F, Scola B, Contreras J, Ruiz A, Carral A, Sanchez-Aniceto G, Pastor M, Herranz JJ, Bernal M, Mesía R. Rueda A, et al. Among authors: mesia r. Oral Oncol. 2017 Jul;70:65-72. doi: 10.1016/j.oraloncology.2017.04.005. Epub 2017 Apr 17. Oral Oncol. 2017. PMID: 28427762 Free article. Review.
[Chemoprevention in cancer of the head and neck].
Sánchez Hernández A, Mesía R, Montes A, Cardenal F. Sánchez Hernández A, et al. Among authors: mesia r. Acta Otorrinolaringol Esp. 1997 Jan-Feb;48(1):1-4. Acta Otorrinolaringol Esp. 1997. PMID: 9131918 Review. Spanish.
Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic.
Chaves ALF, Castro AF, Marta GN, Junior GC, Ferris RL, Giglio RE, Golusinski W, Gorphe P, Hosal S, Leemans CR, Magné N, Mehanna H, Mesía R, Netto E, Psyrri A, Sacco AG, Shah J, Simon C, Vermorken JB, Kowalski LP. Chaves ALF, et al. Among authors: mesia r. Oral Oncol. 2020 Aug;107:104734. doi: 10.1016/j.oraloncology.2020.104734. Epub 2020 Apr 24. Oral Oncol. 2020. PMID: 32353793 Free PMC article. No abstract available.
Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment.
Lozano A, Marruecos J, Rubió J, Farré N, Gómez-Millán J, Morera R, Planas I, Lanzuela M, Vázquez-Masedo MG, Cascallar L, Giralt J, Escames G, Valentí V, Grima P, Bosser R, Tarragó C, Mesía R. Lozano A, et al. Among authors: mesia r. Clin Transl Oncol. 2021 Sep;23(9):1801-1810. doi: 10.1007/s12094-021-02586-w. Epub 2021 Mar 18. Clin Transl Oncol. 2021. PMID: 33738704 Clinical Trial.
146 results